Telomerase-specific oncolytic adenovirus: antitumor effects on radiation-resistant head and neck squamous cell carcinoma cells. 2014

Hideaki Takahashi, and Hiroshi Hyakusoku, and Chihiro Horii, and Masahiro Takahashi, and Goshi Nishimura, and Takahide Taguchi, and Norio Kondo, and Atsuko Sakakibara, and Yasuo Urata, and Daisuke Sano
Department of Otorhinolaryngology and Head and Neck Surgery, Yokohama City University School of Medicine, Yokohama, Japan.

BACKGROUND Radioresistance remains a critical issue in the use of radiotherapy for the treatment of head and neck squamous cell carcinoma (HNSCC). This study evaluated the efficacy of combination treatment with OBP-301, a telomerase-specific replication-selective adenovirus, and radiotherapy in overcoming radioresistance by examining its effect on radiation-resistant HNSCC cells. METHODS Radiation-resistant HNSCC cells were treated with OBP-301 and radiation in vitro and in an orthotopic nude mouse model in vivo and synergism was assessed. Apoptosis and expression of MRN complex, which plays a key role in DNA repair machinery, were also analyzed. RESULTS Infection with OBP-301 was found to enhance the antitumor efficacy of radiation both in vitro and in vivo by inhibiting MRN complex expression and increasing apoptosis induction. CONCLUSIONS Combined OBP-301 and radiation therapy seems to overcome radioresistance in HNSCC cells by inhibiting DNA repair machinery, and may thus be a novel therapeutic strategy for treating HNSCC.

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D009360 Neoplastic Cells, Circulating Exfoliate neoplastic cells circulating in the blood and associated with metastasizing tumors. Circulating Neoplastic Cells,Embolic Tumor Cells,Embolism, Tumor,Neoplasm Circulating Cells,Tumor Cells, Embolic,Cells, Neoplasm Circulating,Circulating Cells, Neoplasm,Circulating Tumor Cells,Cell, Circulating Neoplastic,Cell, Circulating Tumor,Cell, Embolic Tumor,Cell, Neoplasm Circulating,Cells, Circulating Neoplastic,Cells, Circulating Tumor,Cells, Embolic Tumor,Circulating Neoplastic Cell,Circulating Tumor Cell,Embolic Tumor Cell,Embolisms, Tumor,Neoplasm Circulating Cell,Neoplastic Cell, Circulating,Tumor Cell, Circulating,Tumor Cell, Embolic,Tumor Cells, Circulating,Tumor Embolism,Tumor Embolisms
D011839 Radiation, Ionizing ELECTROMAGNETIC RADIATION or particle radiation (high energy ELEMENTARY PARTICLES) capable of directly or indirectly producing IONS in its passage through matter. The wavelengths of ionizing electromagnetic radiation are equal to or smaller than those of short (far) ultraviolet radiation and include gamma and X-rays. Ionizing Radiation,Ionizing Radiations,Radiations, Ionizing
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004260 DNA Repair The removal of DNA LESIONS and/or restoration of intact DNA strands without BASE PAIR MISMATCHES, intrastrand or interstrand crosslinks, or discontinuities in the DNA sugar-phosphate backbones. DNA Damage Response
D005260 Female Females
D006258 Head and Neck Neoplasms Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651) Cancer of Head and Neck,Head Cancer,Head Neoplasm,Head and Neck Cancer,Head and Neck Neoplasm,Neck Cancer,Neck Neoplasm,Neck Neoplasms,Neoplasms, Upper Aerodigestive Tract,UADT Neoplasm,Upper Aerodigestive Tract Neoplasm,Upper Aerodigestive Tract Neoplasms,Cancer of Head,Cancer of Neck,Cancer of the Head,Cancer of the Head and Neck,Cancer of the Neck,Head Neoplasms,Head, Neck Neoplasms,Neoplasms, Head,Neoplasms, Head and Neck,Neoplasms, Neck,UADT Neoplasms,Cancer, Head,Cancer, Neck,Cancers, Head,Cancers, Neck,Head Cancers,Neck Cancers,Neoplasm, Head,Neoplasm, Neck,Neoplasm, UADT,Neoplasms, UADT

Related Publications

Hideaki Takahashi, and Hiroshi Hyakusoku, and Chihiro Horii, and Masahiro Takahashi, and Goshi Nishimura, and Takahide Taguchi, and Norio Kondo, and Atsuko Sakakibara, and Yasuo Urata, and Daisuke Sano
February 2006, Oncology reports,
Hideaki Takahashi, and Hiroshi Hyakusoku, and Chihiro Horii, and Masahiro Takahashi, and Goshi Nishimura, and Takahide Taguchi, and Norio Kondo, and Atsuko Sakakibara, and Yasuo Urata, and Daisuke Sano
February 2007, Oncology reports,
Hideaki Takahashi, and Hiroshi Hyakusoku, and Chihiro Horii, and Masahiro Takahashi, and Goshi Nishimura, and Takahide Taguchi, and Norio Kondo, and Atsuko Sakakibara, and Yasuo Urata, and Daisuke Sano
April 2016, Oncology reports,
Hideaki Takahashi, and Hiroshi Hyakusoku, and Chihiro Horii, and Masahiro Takahashi, and Goshi Nishimura, and Takahide Taguchi, and Norio Kondo, and Atsuko Sakakibara, and Yasuo Urata, and Daisuke Sano
December 2007, Auris, nasus, larynx,
Hideaki Takahashi, and Hiroshi Hyakusoku, and Chihiro Horii, and Masahiro Takahashi, and Goshi Nishimura, and Takahide Taguchi, and Norio Kondo, and Atsuko Sakakibara, and Yasuo Urata, and Daisuke Sano
April 2016, Oncology reports,
Hideaki Takahashi, and Hiroshi Hyakusoku, and Chihiro Horii, and Masahiro Takahashi, and Goshi Nishimura, and Takahide Taguchi, and Norio Kondo, and Atsuko Sakakibara, and Yasuo Urata, and Daisuke Sano
January 2000, Molecular therapy : the journal of the American Society of Gene Therapy,
Hideaki Takahashi, and Hiroshi Hyakusoku, and Chihiro Horii, and Masahiro Takahashi, and Goshi Nishimura, and Takahide Taguchi, and Norio Kondo, and Atsuko Sakakibara, and Yasuo Urata, and Daisuke Sano
January 2015, American journal of cancer research,
Hideaki Takahashi, and Hiroshi Hyakusoku, and Chihiro Horii, and Masahiro Takahashi, and Goshi Nishimura, and Takahide Taguchi, and Norio Kondo, and Atsuko Sakakibara, and Yasuo Urata, and Daisuke Sano
December 2013, Oncology reports,
Hideaki Takahashi, and Hiroshi Hyakusoku, and Chihiro Horii, and Masahiro Takahashi, and Goshi Nishimura, and Takahide Taguchi, and Norio Kondo, and Atsuko Sakakibara, and Yasuo Urata, and Daisuke Sano
August 2011, Head & neck,
Hideaki Takahashi, and Hiroshi Hyakusoku, and Chihiro Horii, and Masahiro Takahashi, and Goshi Nishimura, and Takahide Taguchi, and Norio Kondo, and Atsuko Sakakibara, and Yasuo Urata, and Daisuke Sano
January 2023, Current cancer drug targets,
Copied contents to your clipboard!